Interview with Jitirto Kusnadi, President, Mersifarma
The Indonesian pharmaceutical market has gone through a series of developing phases which have ultimately led the domestic industry to gain the majority of the market share. In this respect…
Address: Wisma Tiara 4th Floor Jl. Raya Pasar Minggu Km. 18 No. 17 Jakarta Indonesia
Tel: +62 21 7987683
Web: http://www.mersifarma.com/
PT Mersifarma TM, better known as “Mersi’, was established in 1997. The company initially focused on the manufacturing of medicines to combat Neuro-Psychiatric, Psychosomatic and Mental Health Diseases. Today other important areas of healthcare in which Mersi is involved are Internal Medicine, Pulmonary Diseases, Obstetrics-Gynaecology, Neuro-surgery, Ear-Nose and Throat Diseases, Dentistry, and advanced antibiotic therapeutic agents.
The Indonesian pharmaceutical market has gone through a series of developing phases which have ultimately led the domestic industry to gain the majority of the market share. In this respect…
Benoit Martineau, President Director at Sanofi Indonesia, explains the transformation of the Indonesian affiliate and reaffirms the strong commitment of Sanofi in helping the Indonesian government to successfully implement their…
Saanjay Shamdasany, Director of Government Affairs & Public Policy at Baxter and Head of the Pharmaceutical and Life Sciences Committee at American Chamber of Commerce Indonesia, explains the importance of…
Suryo Suwignjo, President Director at Philips Indonesia, highlights the strong commitment and contribution of Philips to the development of the Indonesian healthcare system and how medical education is a crucial…
Darodjatun Sanusi, Executive Director of GP Farmasi (National Association of Local Companies in Indonesia), explains the opportunities and challenges that his members are facing as well as the future directions…
Rufi Susanto, President (Core Market) and Senior Managing Director IDS Medical Systems (idsMED), highlights the company’s commitment to Indonesia and believes that idsMED’s employees, in combination with continuous investment in…
Steven Lee, country lead at Siemens Healthineers Indonesia, expands on the strategic change that the company is undergoing in order to fully capture the potential of the Indonesian public and…
Honesti Basyir, president director at Kimia Farma, explains the transition towards digitalization in the healthcare industry and his plans to take Kimia Farma from the top six to the top…
Jonathan Sudharta, member of the the Board of Directors at Mensa Group, shares insights on the vertical integration strategy of Mensa to offer an end-to-end solution as well as shows…
Airlangga Hartarto, Indonesia’s minister of industry, explains the Ministry’s commitment to talent pool development, economic capital availability, and technology implementation within the national industrial landscape. Furthermore, he highlights the role…
Prof. Dr. dr. Fachmi Idris, M.Kes, president director at BPJS Kesehatan explains the evolution of the Universal Healthcare coverage program of Indonesia (JKN-KIS), the challenges inherent in its implementation, and…
Christian Eberle, president director at APL, explains the challenges and opportunities within the Indonesian healthcare distribution arena as well as the company’s strategy to bring more high-quality medicines to patients…
Djonny Hartono Tjahyadi, president director at Enseval, explains the challenges and opportunities within the Indonesian healthcare logistics and distribution arena and his vision to ensure that the company obtains a…
See our Cookie Privacy Policy Here
